ACR Core Component | Canada | Sweden | Overall Study Population |
---|---|---|---|
SJC | –7.3* | –6.7* | –7.1* |
–7.7** | –7.5** | –7.7** | |
TJC | –9.1* | –8.7* | –9.0* |
–10.2** | –7.5** | –9.7** | |
MD global assessment of disease | –33.4* | –40.2* | –35.1* |
–40.5** | –45.6** | –41.5** | |
Patient global assessment of disease | –30.1* | –26.5* | –29.2* |
–32.5** | –22.4** | –30.7** | |
Patient pain | –27.0* | –21.9* | –25.7* |
–27.4** | –23.0** | –26.6** | |
HAQ-DI | –0.5* | –0.3* | –0.4* |
–0.5** | –0.3** | –0.5** | |
ESR, mm/h | –14.3* | –20.6* | –16.0* |
–16.4** | –29.4** | –18.7** | |
CRP, mg/dl | –14.7* | –20.1* | –16.1* |
–12.2** | –28.3** | –15.3** |